Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-erythro-Sphingosine (synthetic) (CAS 6036-75-5)

0.0(0)
Write a reviewAsk a question

Application:
L-erythro-Sphingosine (synthetic) is an inactive isomer of sphingosine
CAS Number:
6036-75-5
Molecular Weight:
299.49
Molecular Formula:
C18H37NO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

L-erythro-Sphingosine, a naturally occurring sphingolipid, plays a pivotal role in the structural and signaling aspects of cellular membranes. As a bioactive lipid, it is involved in the formation of sphingomyelin and glycosphingolipids, which are critical components of the lipid bilayer. L-erythro-Sphingosine′s structure enables it to influence membrane fluidity and microdomain (lipid rafts) organization, which are essential for modulating receptor function and signal transduction pathways. In research, this compound has been extensively utilized to study its intrinsic ability to regulate these pathways, particularly those related to cell growth and survival. The sphingosine backbone of L-erythro-Sphingosine allows for the incorporation of various fatty acids, which can affect its behavior in biological membranes and its interaction with specific proteins, such as sphingosine-1-phosphate receptors. By altering intracellular signaling cascades, researchers can observe changes in cellular responses, providing insights into the mechanisms of action of sphingolipids in cell regulation. Moreover, its role in influencing apoptosis and cellular senescence is of significant interest in understanding the cellular aging process and the maintenance of cellular homeostasis, making L-erythro-Sphingosine a valuable tool in the field of cellular and molecular biology.


L-erythro-Sphingosine (synthetic) (CAS 6036-75-5) References

  1. Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase.  |  El Bawab, S., et al. 2001. J Biol Chem. 276: 16758-66. PMID: 11278489
  2. Chemoenzymatic Synthesis of All Four Stereoisomers of Sphingosine from Chlorobenzene: Glycosphingolipid Precursors(1)(a).  |  Nugent, TC. and Hudlicky, T. 1998. J Org Chem. 63: 510-520. PMID: 11672039
  3. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.  |  Vessey, DA., et al. 2008. J Biochem Mol Toxicol. 22: 113-8. PMID: 18418901
  4. Sphingo-guanidines and their use as inhibitors of sphingosine kinase (WO2010078247).  |  Sharma, AK. 2011. Expert Opin Ther Pat. 21: 807-12. PMID: 21457086
  5. Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.  |  Ahn, EH., et al. 2019. Int J Oncol. 54: 655-664. PMID: 30483770
  6. A series of fluorescent N-acylsphingosines: synthesis, physical properties, and studies in cultured cells.  |  Pagano, RE. and Martin, OC. 1988. Biochemistry. 27: 4439-45. PMID: 3166987
  7. Total synthesis of stereospecific sphingosine and ceramide.  |  Shoyama, Y., et al. 1978. J Lipid Res. 19: 250-9. PMID: 632688
  8. Stereoselectivity of induction of the retinoblastoma gene product (pRb) dephosphorylation by D-erythro-sphingosine supports a role for pRb in growth suppression by sphingosine.  |  Pushkareva, M., et al. 1995. Biochemistry. 34: 1885-92. PMID: 7849048
  9. Regulation of sphingosine-activated protein kinases: selectivity of activation by sphingoid bases and inhibition by non-esterified fatty acids.  |  Pushkareva MYu, ., et al. 1993. Biochem J. 294 (Pt 3): 699-703. PMID: 8379926
  10. The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase.  |  Saba, JD., et al. 1997. J Biol Chem. 272: 26087-90. PMID: 9334171

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

L-erythro-Sphingosine (synthetic), 5 mg

sc-202687
5 mg
$6400.00